Routine

Latent tuberculosis infection

preventive therapy · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Latent TB infection is immune evidence of prior Mycobacterium tuberculosis exposure without active disease. Identifying and treating those at risk of reactivation (immunosuppressed, contacts, new migrants) prevents progression to active TB.

Red flags

  • Cough, fever, night sweats or weight loss (active TB — do not treat as latent)
  • Jaundice or transaminitis on therapy (stop and investigate)
  • Known contact of MDR-TB (specialist regimen needed)
  • Abnormal chest X-ray suggesting active disease

Assessment

Differential diagnosis

  • Active tuberculosis (must be excluded before LTBI treatment)
  • Prior BCG-related tuberculin reactivity
  • Non-tuberculous mycobacterial sensitisation
  • False-positive/negative immune test

Investigations

  • Interferon-gamma release assay (IGRA) or tuberculin skin test
  • Symptom screen and chest X-ray to exclude active disease
  • HIV test and immunosuppression assessment
  • Baseline LFTs before hepatotoxic therapy
  • Risk assessment: contacts, migration from high-incidence country, planned biologic/transplant/dialysis

Management

  • Identify who should be tested (risk of infection AND risk of progression)
  • Perform IGRA or TST to detect infection
  • Exclude active TB with symptom review and chest radiography before treating
  • Assess risk-benefit: likelihood of reactivation versus hepatotoxicity
  • Check baseline liver function and screen for HIV and hepatitis
  • Discuss and start a preferred short-course rifamycin-based regimen
  • Counsel on adherence, drug interactions and hepatotoxicity warning signs
  • Monitor for adverse effects and complete the course
  • Document completion and advise on future symptoms of active TB
  • Coordinate timing with planned immunosuppression / biologic therapy

Drugs & doses

Rifampicin 600 mg PO once daily for 4 months (preferred short course)
Isoniazid 300 mg PO once daily + pyridoxine 25 mg daily for 6 months (alternative)
Rifapentine + isoniazid weekly for 12 weeks (3HP) where available
Rifampicin + isoniazid 3 months (3HR) as an alternative

Disposition

TB service / primary care with specialist oversight; coordinate with the service prescribing immunosuppression.

Complications & pitfalls

  • Progression to active tuberculosis if untreated
  • Drug-induced hepatitis
  • Rifamycin drug interactions (contraceptives, antiretrovirals, anticoagulants)
  • Peripheral neuropathy from isoniazid

Exam pearls

  • Always exclude active TB before giving single-agent preventive therapy to avoid resistance
  • Rifamycin-based short courses have better completion and less hepatotoxicity than 6-9 months isoniazid
  • IGRA is unaffected by prior BCG vaccination, unlike the tuberculin test
  • Treat LTBI before starting anti-TNF biologics or transplant immunosuppression

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.